| Title | Cancer Treatment and Research Communications |
| Abbreviation | Cancer Treat. Res. Commun. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Oncology (Q2); Cancer Research (Q3) |
| h-index | 23 |
| Overall Rank/Ranking | 6300 |
| SCImago Journal Rank (SJR) | 0.793 |
| Impact Score | 2.49 |
| Publisher | Elsevier Ltd |
| Country | United Kingdom |
| ISSN | 24682942 |
| Best Quartile | Q2 |
| Coverage History | 2016-2023 |
Cancer Treatment and Research Communications is a journal covering the technologies/fields/categories related to Oncology (Q2); Cancer Research (Q3). It is published by Elsevier Ltd. The overall rank of Cancer Treatment and Research Communications is 6300. According to SCImago Journal Rank (SJR), this journal is ranked 0.793. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 23. The best quartile for this journal is Q2.
The ISSN of Cancer Treatment and Research Communications journal is 24682942. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Cancer Treatment and Research Communications is cited by a total of 1166 articles during the last 3 years (Preceding 2023).
The Impact IF 2023 of Cancer Treatment and Research Communications is 2.49, which is computed in 2024 as per its definition. Cancer Treatment and Research Communications IF is decreased by a factor of 0.03 and approximate percentage change is -1.19% when compared to preceding year 2022, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2023 of Cancer Treatment and Research Communications is 2.49. If the same downward trend persists, Impact IF may fall in 2024 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 2.49 |
| 2022 | 2.52 |
| 2021 | 2.00 |
| 2020 | 1.56 |
| 2019 | 0.53 |
| 2018 | 0.60 |
| 2017 | 0.43 |
| 2016 | 0.37 |
| 2015 | 0.31 |
| 2014 | 0.20 |
Cancer Treatment and Research Communications has an h-index of 23. It means 23 articles of this journal have more than 23 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Cancer Treatment and Research Communications is 24682942. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Cancer Treatment and Research Communications is 6300. According to SCImago Journal Rank (SJR), this journal is ranked 0.793. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 0.793 |
| 2022 | 0.674 |
| 2021 | 0.520 |
| 2020 | 0.459 |
| 2019 | 0.256 |
| 2018 | 0.297 |
| 2017 | 0.250 |
| 2016 | 0.182 |
| 2015 | 0.113 |
| 2014 | 0.146 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 6300 |
| 2022 | 7460 |
| 2021 | 9620 |
| 2020 | 10819 |
| 2019 | 15944 |
| 2018 | 13810 |
| 2017 | 15037 |
| 2016 | 18877 |
| 2015 | 25944 |
| 2014 | 20972 |
Cancer Treatment and Research Communications is published by Elsevier Ltd. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 2016-2023. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Cancer Treatment and Research Communications is Cancer Treat. Res. Commun.. This abbreviation ('Cancer Treat. Res. Commun.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Oncology (Q2); Cancer Research (Q3), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Cancer Treatment and Research Communications latest impact IF is 2.49. It's evaluated in the year 2023. The highest and the lowest impact IF or impact score of this journal are 2.52 (2022) and 0.20 (2014), respectively, in the last 10 years. Moreover, its average IS is 1.1 in the previous 10 years.
The Cancer Treatment and Research Communications has an SJR (SCImago Journal Rank) of 0.793, according to the latest data. It is computed in the year 2024. In the past 10 years, this journal has recorded a range of SJR, with the highest being 0.793 in 2023 and the lowest being 0.113 in 2015. Furthermore, the average SJR of the Cancer Treatment and Research Communications over the previous 10-year period stands at 1.1.
The latest h-index of the Cancer Treatment and Research Communications is 23.
The Cancer Treatment and Research Communications is published by the Elsevier Ltd, with its country of publication being the United Kingdom.
The Cancer Treatment and Research Communications is currently ranked 6300 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 10 years, this journal has experienced varying rankings, reaching its highest position of 6300 in 2023 and its lowest position of 25944 in 2015.
The standard ISO4 abbreviation for the Cancer Treatment and Research Communications is Cancer Treat. Res. Commun..
Cancer Treatment and Research Communications is classified as a journal that the Elsevier Ltd publishes.
The Cancer Treatment and Research Communications encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Cancer Treatment and Research Communications is assigned the following International Standard Serial Numbers (ISSN): 24682942.
The best quartile for the Cancer Treatment and Research Communications is Q2 (2023).
The Cancer Treatment and Research Communications coverage history can be summarized as follows: 2016-2023.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Zeitschrift fur Germanistische Linguistik | journal | 14988 | Walter de Gruyter GmbH | 16 | 0.40 |
| Revue Francophone des Laboratoires (discontinued) | journal | 23244 | Elsevier Masson s.r.l. | 8 | 0.00 |
| CESifo Economic Studies | journal | 9721 | Oxford University Press | 34 | 0.89 |
| International Journal of Parallel, Emergent and Distributed Systems | journal | 16153 | Taylor and Francis Ltd. | 25 | 1.10 |
| Marine Biology Research | journal | 14120 | Taylor and Francis Ltd. | 45 | 1.02 |
| Journal, Indian Academy of Clinical Medicine | journal | 26979 | Indian Academy of Clinical Medicine | 16 | 0.10 |
| Journal of Sociolinguistics | journal | 3273 | Wiley-Blackwell Publishing Ltd | 64 | 1.85 |
| Educational Measurement: Issues and Practice | journal | 5979 | Wiley-Blackwell Publishing Ltd | 64 | 1.67 |
| Proceedings of the International Semiconductor Conference, CAS | conference and proceedings | 25734 | Institute of Electrical and Electronics Engineers Inc. | 16 | 0.00 |
| European Journal of Cancer, Supplement | journal | 6710 | Elsevier Ltd | 29 | 0.33 |
| Year | Impact Score (IS) |
|---|---|
| 2024/2025 | Coming Soon |
| 2023 | 2.49 |
| 2022 | 2.52 |
| 2021 | 2.00 |
| 2020 | 1.56 |
| 2019 | 0.53 |
| 2018 | 0.60 |
| 2017 | 0.43 |
| 2016 | 0.37 |
| 2015 | 0.31 |
| 2014 | 0.20 |
